C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
260/606, 260/335
C07D 295/02 (2006.01) C07C 87/02 (1980.01) C07C 91/06 (1980.01)
Patent
CA 1078837
ABSTRACT OF THE DISCLOSURE: n-Butylamine derivatives having the general formula: Image I and the pharmaceutically acceptable acid addition salts thereof wherein R4 represents hydrogen, propargyl or 2-hydroxyethyl, R5 represents methyl, propargyl, 2-hydroxyethyl, 3-hydroxy-n- propyl or R4 and R5, when they are taken together, represent methylene, ethylene, trimethylene, ethylidene or -CH2-CH2-O- CH2-CH2- and R2 is such that : - when R4 repsesents hydrogen and R5 represents methyl, R2 represents n-propyl, isopropyl, isobutyl or allyl - when R4 represents hydrogen and R5 represents propargyl, 2-hydroxyethyl or 3-hydroxy-n-propyl or when R4 and R5 are identical and each represent propargyl or 2-hydroxyethyl or when R4 and R5 are taken together and represent methylene, ethylene, trimethylene, ethylidene or -CH2-CH2-O-CH2-CH2-, then R2 represents n-propyl. These derivatives present central noradrenergic and central dopaminergic properties which make them useful in treating Parkinson's desease as well as for correcting extra- pyramidal disturbances provoked by neuroleptics.
338050
Broll Madeleine
Eymard Pierre
Pigerol Charles
Vernieres Jean-Claude
LandOfFree
Active derivatives of methylamine, therapeutic compositions... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Active derivatives of methylamine, therapeutic compositions..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Active derivatives of methylamine, therapeutic compositions... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-251610